Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomesAlessia Castellino, Grzegorz S. Nowakowski, Yucai Wang et al.|Blood Advances|2021Cited by 23
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United StatesChristopher R. Flowers, James R. Cerhan, Brian K. Link et al.|Blood|2018Cited by 9
Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell LymphomaNamrata Singh, Brian K. Link, James R. Cerhan et al.|Blood|2019Cited by 8
Comparing Clinical Characteristics and Outcomes of <i>MYC</i> and <i>BCL6</i> Double Hit Lymphoma (DHL- <i>BCL6</i>) with Other Aggressive B-Cell Lymphomas: Understanding the Impact of New Who and International Consensus ClassificationsArushi Khurana, Rebecca L. King, Kiran Vij et al.|Blood|2023Cited by 8
Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic SyndromeAnjali Sharathkumar, Sarah L. Mott, J. Walter Carr et al.|Journal of Pediatric Hematology/Oncology|2024Cited by 3